In Vitro Toxicology Testing Market

The in vitro toxicology testing market is projected to reach USD 20.97 billion by 2031, growing from an estimated USD 12.69 billion in 2026, at a CAGR of 10.6%. The major factors driving growth in the in vitro toxicology testing market include the increasing shift away from animal testing, rising adoption of advanced non-animal testing technologies, and growing demand for early-stage toxicity detection across drug discovery, cosmetics, chemicals, food, and medical device development.

The global in vitro toxicology testing market is competitive with top players such as Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Revvity (US) and Laboratory Corporation of America Holdings (US), among a few others, dominating. These players have adopted various strategies, such as product/service launches, acquisitions, agreements, collaborations, and geographical expansions, to strengthen their position in the global in vitro toxicology testing market.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific is a leading IVTT player supported by its broad portfolio of cell culture products, cytotoxicity and cell viability assays, imaging reagents, microplate assays, flow cytometry, high-content analysis tools, and lab workflow solutions. Its strength lies in combining consumables, instruments, software, and global distribution for pharma, biotech, CRO, academic, cosmetic, and chemical safety testing customers. The company also explores strategic agreements with academic institutes, as these institutes conduct research studies that make use of in vitro techniques. In March 2023, Thermo Fisher Scientific collaborated with King’s Forensics (UK). With the help of this partnership, researchers at King’s Forensics got access to the latest and best tools to help them with their studies on drug toxicity.

Agilent Technologies, Inc. (US)

Agilent is a leading analytical and cell-analysis player in IVTT, offering tools for drug toxicity assessment, in vitro assays, 3D cell culture analysis, high-throughput cell-based screening, Seahorse XF metabolism analysis, and xCELLigence real-time cell monitoring. Its platforms support toxicology, cellular stress, metabolic toxicity, and environmental toxicity workflows. The launch of new instruments and software, and expansion, helped Agilent Technologies gain market share in the in vitro toxicology testing market. In 2022, Agilent Technologies invested around USD 20 million to expand its manufacturing facility in Shanghai, responding to the increasing demand in China for the company’s advanced liquid chromatography (LC) spectrometer and mass spectroscopy (MS) systems. This helped Agilent to increase its global presence in the market and meet the growing demand for its products in emerging markets.

Merck KGaA (Germany)

Merck is a leading science and technology company with a strong global presence in more than 120 countries. The company has a portfolio of more than 300,000 life science products that support a broad customer base. Merck majorly focuses on expansions in key geographies to increase its customer base. It is a leading IVTT product supplier through Sigma-Aldrich/Millipore portfolios, including MTT, LDH, resazurin, neutral red, SRB-based in vitro toxicology kits, cytotoxicity assays, cell culture reagents, and genotoxicity multiplex tools. Its recurring consumables base strengthens its role in cell-based and mechanistic toxicity workflows.

Market Ranking

The in vitro toxicology testing market is moderately consolidated and highly competitive, with the top five players estimated to account for around 35–40% of global revenues. Leading companies such as Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Charles River Laboratories, and Eurofins Scientific maintain strong positions through broad portfolios spanning assay kits, reagents, cell culture products, analytical instruments, high-content screening platforms, predictive toxicology tools, and CRO-based testing services.

Thermo Fisher Scientific leads through its integrated life science tools, assays, reagents, cell analysis, and laboratory workflow ecosystem. Agilent is strong in analytical toxicology, cellular analysis, imaging, and screening platforms, while Merck KGaA supports the market through cell culture, reagents, assay tools, and life science consumables.
The remaining 60–65% of the market consists of specialized CROs, organ-on-chip developers, 3D cell model providers, bioinformatics companies, regional testing labs, and niche reagent suppliers.

Related Reports:

In Vitro Toxicology Testing Market by Product (Equipment, Reagents, Kits, Software), Toxicity Endpoints & Type, Technology (Cell Culture, HTS), Method (Cell-based, Computational), Service (Type, Method), Region, Competition - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]